Aranesp and Pleurisy - a phase IV clinical study of FDA data

Summary:

Pleurisy is reported as a side effect among people who take Aranesp (darbepoetin alfa), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Pleurisy when taking Aranesp. It is created by eHealthMe based on reports of 54,218 people who have side effects when taking Aranesp from the FDA, and is updated regularly.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 814 drugs and 1,140 conditions by eHealthMe. Check the latest studies of Pleurisy.

On Jul, 13, 2026

54,218 people reported to have side effects when taking Aranesp.
Among them, 40 people (0.07%) have Pleurisy.

Among these 40 people:

How long have people been on Aranesp when they have Pleurisy? *

What is the gender of people who have Pleurisy when taking Aranesp? *

female: 82.5 %
male: 17.5 %

What is the age of people who have Pleurisy when taking Aranesp? *

What are other drugs people take besides Aranesp? *

What are other side effects people have besides Pleurisy? *

Pain: 26 people, 65.00%
Stress And Anxiety: 24 people, 60.00%
Pleural Effusion (water on the lungs): 23 people, 57.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 23 people, 57.50%
Herpes Zoster: 22 people, 55.00%
Pneumonia: 22 people, 55.00%
Osteopenia (a condition where bone mineral density is lower than normal): 22 people, 55.00%
Osteonecrosis Of Jaw (death of bone of jaw): 22 people, 55.00%
Infection: 22 people, 55.00%
Dyspnea (difficult or laboured breathing): 21 people, 52.50%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 32.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.00%
Nausea And Vomiting: 2 people, 5.00%
Nausea (feeling of having an urge to vomit): 2 people, 5.00%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 5.00%
Cytogenetic Abnormality: 2 people, 5.00%
Diabetes: 1 person, 2.50%
Acute Kidney Failure: 1 person, 2.50%
Anaemia Of Malignant Disease: 1 person, 2.50%
Bipolar Disorder (mood disorder): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Aranesp and have Pleurisy?

- Check whether Pleurisy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aranesp:

Aranesp (54,331 reports)

Pleurisy treatments and more:

Pleurisy (9,090 reports)

Browse all side effects of Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleurisy:

Pleurisy (814 drugs)

Browse all the conditions that are associated with Pleurisy:

Pleurisy (1,140 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darbepoetin alfa (the active ingredients of Aranesp) and Aranesp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.